Design of de novo peptides and electrophysiological testing for voltage-gated sodium channel 1.7 inhibition related to chronic pain treatment
与慢性疼痛治疗相关的电压门控钠通道 1.7 抑制的从头肽设计和电生理学测试
基本信息
- 批准号:10660928
- 负责人:
- 金额:$ 4.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-03 至 2024-12-02
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsAdultAffinityAmericanBenchmarkingBindingBiological AssayBiological ProductsBiological Response Modifier TherapyCardiacCellsChargeClinicalCommunicationComplexComputational ScienceCryoelectron MicroscopyDataDevelopmentDisulfidesDrug DesignElectrophysiology (science)FamilyGeneticHeart ArrestHumanHuman GeneticsHydrophobicityIndustry CollaborationIntegral Membrane ProteinInvestigationIon ChannelKnowledgeLearningLibrariesManualsMethodologyMethodsModificationMutagenesisMutateNeurobiologyNeurosciencesNeurotoxinsNociceptionPain managementParalysedPathologyPeptidesPeripheral Nervous SystemPeruvianPharmaceutical PreparationsPositioning AttributeProtein EngineeringProteinsPublishingResearchResolutionSafetyScorpionsSeizuresSideSodiumSodium ChannelSoftware DesignSpidersStructureTestingTherapeuticTimeToxinTrainingTranslational ResearchValidationVariantWorkacademic preparationaddiction liabilitycareerchemical stabilitychronic painchronic pain managementclinical efficacycytokinedesigndrug candidatedrug discoveryeffective therapyexperienceexperimental studyfallsimprovedknowledgebasemimeticsnanomolarneuronal excitabilitynon-opioid analgesicnovelpain signalpatch clamppeptidomimeticspre-clinicalprescription opioidpreservationprotein structure predictionrational designscreeningskeletalskillssmall moleculestructural imagingtargeted treatmentthermostabilityvalidation studiesvirtual screeningvoltage
项目摘要
Project Summary/Abstract
Current drug discovery efforts for non-addictive, chronic pain management are targeting human voltage-gated
sodium (hNaV) channels: pore-forming transmembrane proteins that evoke the fast action potential in excitable
neuronal, cardiac, and skeletal cells. Genetic and preclinical target validation studies have identified hNaV1.7,
hNaV1.8, hNaV1.9 channel subtypes as key proteins in pain signaling with emphasis on hNaV1.7 for its
predominant expression in the peripheral nervous system. Attempts at selectively targeting hNaV1.7 with pre-
clinical small-molecule drugs fall short due to non-selective binding to other hNaV channel subtypes and other
ion channel families; non-selective binding can lead to cardiac arrest, paralysis and seizure. Peptide toxins
originating from tarantula, spider, and scorpion have been identified as potent hNaV-inhibiting biologics.
Notably, Protoxin-II, the neurotoxin from the Peruvian green velvet tarantula, has approximately 1 nM half-
maximal inhibitory concentration (IC50) to hNav1.7. However, these peptide toxins also have non-selective
binding to hNav1.7. With recent cryo-EM structural images of Protoxin-II bound to voltage-sensing domain II of
hNaV1.7, it is now possible to design peptides mimicking Protoxin-II that are selective to hNaV1.7. Advances in
de novo protein design methods using Rosetta – a protein structure prediction and design software suite –
enable a new avenue of drug design and virtual screening prior to experimental validation. Thus, the project
aims to create new peptides inspired from Protoxin-II to selectively target hNaV1.7. The methodology designs
new peptide topologies that incorporate the Protoxin-II motif structurally shown to bind to hNaV1.7. The
peptides are further optimized to bind to residues unique to hNaV1.7: residues that are not targeted by natural
peptide toxins. Upon synthesis of candidate peptides, they will be validated to selectively target hNaV1.7 using
whole-cell patch-clamp electrophysiology. The results will improve our mechanistic understanding needed for
selective, yet potent hNaV1.7 inhibition. Further, this research will be the first attempt at using a combination of
Rosetta de novo protein design methods to create unique peptides selective for hNaV1.7. The applicant upon
completion of this project will have a refined expertise of computational protein design methods and receive
training in electrophysiology for the first time. Throughout this project, the sponsor and co-sponsor will
implement a training plan to strengthen the applicant’s knowledge of neuroscience and drug discovery, while
broadening their collaborative network, and sharpening their scientific communication skills. This plan is
tailored such that the applicant is prepared for an academic career designing peptide biologics for the
treatment and investigation of ion channel pathologies.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brandon John Harris其他文献
Brandon John Harris的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brandon John Harris', 18)}}的其他基金
Design of de novo peptides and electrophysiological testing for voltage-gated sodium channel 1.7 inhibition related to chronic pain treatment
与慢性疼痛治疗相关的电压门控钠通道 1.7 抑制的从头肽设计和电生理学测试
- 批准号:
10389511 - 财政年份:2022
- 资助金额:
$ 4.04万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 4.04万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 4.04万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 4.04万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 4.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 4.04万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 4.04万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 4.04万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 4.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 4.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 4.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)